Biocryst Pharmaceuticals Inc (BCRX)
Stock-Based Compensation
$14.69M
Quarterly · Period ending: · USD
BCRX Stock-Based Compensation
Latest reported$14.69Mperiod ending
Latest reported$14.69Mperiod ending
BCRX Quarterly Stock-Based Comp ($0.00 → $14.69M)
Quarterly stock-based compensation
High-resolution chart · PNG
BCRX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 14,692,000 | |
| 16,027,000 | |
| 72,568,000 | |
| 18,601,000 | |
| 21,304,000 | |
| 21,368,000 | |
| 21,339,000 | |
| 17,249,000 | |
| 13,173,000 | |
| 13,652,000 | |
| 16,488,000 | |
| 12,279,000 | |
| 12,841,000 | |
| 14,007,000 | |
| 15,282,000 | |
| 9,951,000 | |
| 9,867,000 | |
| 9,601,000 | |
| 8,500,000 | |
| 13,029,000 | |
| 7,632,000 | |
| 5,479,000 | |
| 5,887,000 | |
| 2,873,000 | |
| 3,280,000 | |
| 2,754,000 | |
| 3,688,000 | |
| 5,329,000 | |
| 5,385,000 | |
| 3,317,000 | |
| 2,324,000 | |
| 2,085,000 | |
| 2,084,000 | |
| 2,903,000 | |
| 2,314,000 | |
| 5,519,000 | |
| 2,326,000 | |
| 2,462,000 | |
| 2,009,000 | |
| 1,987,000 | |
| 1,846,000 | |
| 2,645,000 | |
| 1,932,000 | |
| 1,839,000 | |
| 3,675,000 | |
| 2,259,000 | |
| 3,627,000 | |
| 1,421,000 | |
| 3,519,000 | |
| 1,610,000 | |
| 889,000 | |
| 958,000 | |
| 919,000 | |
| 1,602,000 | |
| 822,000 | |
| 1,167,000 | |
| 1,134,000 | |
| 1,044,000 | |
| 900,000 | |
| 1,144,000 | |
| 1,261,000 | |
| 1,467,000 | |
| 1,307,856 | |
| 1,428,000 | |
| 2,160,000 | |
| 1,406,000 | |
| 1,345,883 | |
| 1,385,000 | |
| 1,466,000 | |
| 1,328,000 | |
| 5,860,654,000 | |
| 0 | |
| 0 | |
| 2,453,000 | |
| 5,691,028,000 | |
| 0 | |
| 0 | |
| 0 | |
| 26,392,000 | |
| 7,000 | |
| 6,000 | |
| 0 | |
| 26,392,000 | |
| 13,000 | |
| 303,000 | |
| 13,000 | |
| 512,427,000 | |
| 1,000 | |
| 0 | |
| 0 | |
| 119,676,000 | |
| 0 | |
| 0 | |
| 0 | |
| 120,190,000 | |
| 0 | |
| 0 | |
| 0 | |
| 123,289,000 | |
| 0 |